1. Home
  2. NWPX vs HUMA Comparison

NWPX vs HUMA Comparison

Compare NWPX & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NWPX
  • HUMA
  • Stock Information
  • Founded
  • NWPX 1966
  • HUMA 2004
  • Country
  • NWPX United States
  • HUMA United States
  • Employees
  • NWPX N/A
  • HUMA N/A
  • Industry
  • NWPX Steel/Iron Ore
  • HUMA Biotechnology: Pharmaceutical Preparations
  • Sector
  • NWPX Industrials
  • HUMA Health Care
  • Exchange
  • NWPX Nasdaq
  • HUMA Nasdaq
  • Market Cap
  • NWPX N/A
  • HUMA 221.8M
  • IPO Year
  • NWPX 1995
  • HUMA N/A
  • Fundamental
  • Price
  • NWPX $38.56
  • HUMA $1.21
  • Analyst Decision
  • NWPX Hold
  • HUMA Strong Buy
  • Analyst Count
  • NWPX 1
  • HUMA 6
  • Target Price
  • NWPX $55.00
  • HUMA $14.60
  • AVG Volume (30 Days)
  • NWPX 56.0K
  • HUMA 2.9M
  • Earning Date
  • NWPX 04-30-2025
  • HUMA 05-20-2025
  • Dividend Yield
  • NWPX N/A
  • HUMA N/A
  • EPS Growth
  • NWPX 37.25
  • HUMA N/A
  • EPS
  • NWPX 3.27
  • HUMA N/A
  • Revenue
  • NWPX $495,448,000.00
  • HUMA N/A
  • Revenue This Year
  • NWPX $2.48
  • HUMA N/A
  • Revenue Next Year
  • NWPX $4.49
  • HUMA $1,178.20
  • P/E Ratio
  • NWPX $11.40
  • HUMA N/A
  • Revenue Growth
  • NWPX 8.06
  • HUMA N/A
  • 52 Week Low
  • NWPX $32.04
  • HUMA $1.15
  • 52 Week High
  • NWPX $57.76
  • HUMA $9.97
  • Technical
  • Relative Strength Index (RSI)
  • NWPX 39.53
  • HUMA 30.35
  • Support Level
  • NWPX $36.97
  • HUMA $1.35
  • Resistance Level
  • NWPX $42.88
  • HUMA $1.48
  • Average True Range (ATR)
  • NWPX 1.42
  • HUMA 0.10
  • MACD
  • NWPX -0.34
  • HUMA 0.03
  • Stochastic Oscillator
  • NWPX 25.08
  • HUMA 4.26

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: